Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Post by Trek1701on Jan 29, 2022 3:37pm
276 Views
Post# 34375036

Covid Immunity Passport site

Covid Immunity Passport siteThe covidimmunitypassport.com site has been down for weeks and I suspect it's not coming back.

Dr. Chin's health in a box site still advertises the test for now but who knows for how long: https://healthinabox.com/product/standard-covid-19-antibodies-testing/

Since there has been no mention of revenue from ProMIS financial statements, I think test sales have been less than aducan, maybe close to $0.00

I don't understand how or why ProMIS can continue to add programs (schizophrenia being the latest) with no revenue to fund them. I'm reminded of the "focus, focus" mantra when the company relaunched and programs like cancer, scrapie and vCJD were shelved. I hope history doesn't repeat. People were loudly sounding the alarm at that time as well. 
 
<< Previous
Bullboard Posts
Next >>